36 min listen
007: Quality Data For FDA Submissions With Dr. Robert Hariri
007: Quality Data For FDA Submissions With Dr. Robert Hariri
ratings:
Length:
39 minutes
Released:
Sep 8, 2020
Format:
Podcast episode
Description
If ever a biotech unwittingly begged for FDA scrutiny by virtue of its business model, it was Celularity. The company is working on a host of biologic therapies, the development of which is dependent on the large-scale collection of stem cells harvested from afterbirth in maternity wards across the globe. That's an approach that simply begs for FDA oversight, which is why Celularity founder Dr. Robert Hariri makes for an excellent discussion on the importance of data quality and complete master files for FDA submissions.
Released:
Sep 8, 2020
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform by Business Of Biotech